News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China National Biotech Group's Japanese Encephalitis Vaccine Prequalified by World Health Organization


10/9/2013 12:57:41 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

October 9, 2013 -- A Japanese encephalitis vaccine produced by China National Biotec Group (CNBG), a subsidiary of state-owned Sinopharm, was prequalified by the World Health Organization. It is the first JE vaccine to be prequalified for use in children and the first-ever China vaccine to be granted WHO prequalification. The certification allows UN organizations to buy the vaccine and distribute it in less-developed countries. PATH, a nonprofit health organization, assisted CNBG. The agency was very interested in promoting a China vaccine because the low cost would facilitate distribution. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES